Neurolief
Neurolief54
About
What does Neurolief do?
Neurolief is a medical device company focused on developing non-invasive neuromodulation technology for the treatment of neurological and neuropsychiatric disorders. Their primary product, the Relivion system, is a brain neuromodulation device designed to provide relief for conditions such as migraine and depression by stimulating specific brain regions.
What is Neurolief's revenue?
StartupHub estimates Neurolief's annual revenue at $9.0M (range $5.7M to $14.4M, 67% confidence), based on comparable companies in the sector.
What is Neurolief's valuation?
StartupHub estimates Neurolief's effective valuation at $61.2M (range $37.5M to $90.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Neurolief raised?
Neurolief has raised a total of $15M in funding. The most recent round on record is Series A.
Where is Neurolief headquartered?
Neurolief is headquartered in Netanya, Israel.
When was Neurolief founded?
Neurolief was founded in 2013.
What industry does Neurolief operate in?
Neurolief operates in Healthcare, Brain, Migraine, Neuromodulation, Wearable, MedTech.
How many employees does Neurolief have?
Neurolief has approximately 30 people on record.
An entrant is a company tagged Healthcare whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.